U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07236710) titled 'Observation of Strategies in Placenta Accreta Spectrum Management' on Nov. 15.
Brief Summary: * Placenta accreta spectrum (PAS) disorders represent a significant obstetric challenge, characterized by abnormal adherence of the placenta to the uterine wall, leading to potentially life-threatening hemorrhage (ACOG 2020; RCOG 2018; Jauniaux 2019) during delivery. PAS includes placenta accreta (attachment to the myometrium), increta (invasion into the myometrium), and percreta (penetration through the uterine serosa, often involving adjacent organs). The incidence of PAS is rising globally, largely attributed to the increased rates of ce...